Sanofi, Translate Bio expand mRNA vaccine partnership in $2.3bn worth deal

This article was originally published here

The French vaccines company, which is part of Sanofi, signed a collaboration and license agreement deal worth up to $805m with Translate Bio in 2018 for developing mRNA

The post Sanofi, Translate Bio expand mRNA vaccine partnership in $2.3bn worth deal appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply